Not finding it? Sign in to also search OpenAlex live.
-
Phase I/II Study of AXL-Specific Antibody–Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors2025 Cancer Research Communications article Medicine Lung Cancer Treatments and Mutations Open access cited by 1 patent
Kristoffer Staal Rohrberg, Juanita Suzanne Lopez, Mohammed M. Milhem, Christian U. Blank, Irene L. M. Reijers, Fiona C. Thistlethwaite, +34 more
5citations -
Tub-010, a Novel Antibody-Drug-Conjugate with Reduced Nonspecific Toxicity Profile Based on Tub-Tag Technology Widens the Therapeutic Window for the Treatment of CD30+ Malignancies
Marcus Gerlach, Saskia Schmitt, Philipp Cyprys, Marc‐André Kasper, Isabelle Mai, Maarten H. Vermeer, +5 more
3citations
3 results